Recruiting
Phase 2

A Study to Investigate the Differential Effects of Inhaled Symbicort and Advair on Lung Microbiota

Sponsor:

University of British Columbia

Code:

NCT02833480

Conditions

Chronic Obstructive Pulmonary Disease

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Fluticasone group

Budesonide group

Formoterol group

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-24. This information was provided to ClinicalTrials.gov by University of British Columbia on 2020-03-30.